Factor VII, Tissue Factor Pathway Inhibitor, and Monocyte Tissue Factor in Diabetes Mellitus: Influence of Type of Diabetes, Obesity Index, and Age
- 1 March 2001
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 101 (5) , 367-375
- https://doi.org/10.1016/s0049-3848(00)00424-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Microalbuminuria in IDDM is associated with increased expression of monocyte procoagulant activityDiabetologia, 1998
- Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with Type II (non-insulin-dependent) diabetes mellitusDiabetologia, 1998
- Advanced Glycation End Product (AGE)–Mediated Induction of Tissue Factor in Cultured Endothelial Cells Is Dependent on RAGECirculation, 1997
- Moderate weight reduction improves red cell aggregation and factor VII activity in overweight subjectsInternational Journal of Obesity, 1997
- Tissue Factor in the Pathogenesis of AtherosclerosisThrombosis and Haemostasis, 1997
- Mechanism on Disorders of Coagulation and Fibrinolysis in DiabetesDiabetes, 1996
- Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Cultured normal human hepatocytes do not synthesize lipoprotein-associated coagulation inhibitor: evidence that endothelium is the principal site of its synthesis.Proceedings of the National Academy of Sciences, 1990
- Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitorNature, 1989
- Blood glucose may condition factor VII levels in diabetic and normal subjectsDiabetologia, 1988